Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Techne (TECH) Net Margin (2016 - 2026)

Bio-Techne has reported Net Margin over the past 17 years, most recently at 12.85% for Q4 2025.

  • For Q4 2025, Net Margin rose 110.0% year-over-year to 12.85%; the TTM value through Dec 2025 reached 0.47%, down 1278.0%, while the annual FY2025 figure was 1.1%, 1466.0% down from the prior year.
  • Net Margin for Q4 2025 was 12.85% at Bio-Techne, down from 13.33% in the prior quarter.
  • Over five years, Net Margin peaked at 4486.7% in Q3 2022 and troughed at 67.03% in Q2 2022.
  • A 5-year average of 231.13% and a median of 14.24% in 2023 define the central range for Net Margin.
  • Biggest five-year swings in Net Margin: soared 445993bps in 2022 and later plummeted -446829bps in 2023.
  • Year by year, Net Margin stood at 26.76% in 2021, then tumbled by -31bps to 18.41% in 2022, then crashed by -45bps to 10.08% in 2023, then grew by 17bps to 11.75% in 2024, then rose by 9bps to 12.85% in 2025.
  • Business Quant data shows Net Margin for TECH at 12.85% in Q4 2025, 13.33% in Q3 2025, and 32.97% in Q2 2025.